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Maternal Glucose Concentrations in Early Pregnancy  
and Cardiometabolic Risk Factors in Childhood
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Vincent W.V. Jaddoe 1,2, and Romy Gaillard 1,2
Objective: This study aimed to examine the associations of maternal 
early-pregnancy glucose and insulin concentrations with offspring car-
diometabolic risk factors and fat distribution.
Methods: In a population-based prospective cohort study among 
3,737 mothers and their children, random maternal glucose and insu-
lin concentrations were measured at a median gestational age of 13.2 
(95% range 10.5-17.1) weeks. Childhood fat, blood pressure, and blood 
concentrations of lipids, glucose, and insulin at the age of 10 years were 
measured.
Results: Higher maternal early-pregnancy glucose and insulin concen-
trations were associated with a higher risk of childhood overweight, and 
higher maternal early-pregnancy insulin concentrations were associated 
with an increased childhood risk of clustering of cardiometabolic risk fac-
tors (all P < 0.05). These associations were explained by maternal prepreg-
nancy BMI. Independent of maternal prepregnancy BMI, one SD score 
(SDS) higher maternal early-pregnancy glucose and insulin concentra-
tions were associated with higher childhood glucose (0.08 SDS, 95% CI: 
0.04-0.11) and insulin concentrations (0.07 SDS, 95% CI: 0.03-0.10), but 
not with childhood blood pressure, lipids, and fat measures.
Conclusions: These results suggest that maternal early-pregnancy ran-
dom glucose and insulin concentrations are associated with childhood 
glucose and insulin concentrations but not with other childhood cardio-
metabolic risk factors.
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Study Importance
What is already known?
►	Gestational diabetes is associated with 
increased risks of offspring obesity, type 
2 diabetes, and metabolic syndrome.
►	Maternal glucose concentrations in mid- 
and late pregnancy below the diagnostic 
threshold of gestational diabetes may 
already be associated with childhood 
cardiometabolic risk factors.
What does this study add?
►	Higher maternal early-pregnancy glu-
cose and insulin concentrations are as-
sociated with higher childhood glucose 
and insulin concentrations, independent 
of maternal socioeconomic and lifestyle 
factors and birth, infant, and childhood 
characteristics.
►	Associations of maternal early-preg-
nancy glucose and insulin concentrations 
with childhood overweight, clustering of 
cardiometabolic risk factors, blood pres-
sure, lipids, and detailed measures of fat 
are explained by maternal prepregnancy 
BMI.
How might these results change the 
focus of clinical practice?
►	Children with an increased risk of glu-
cose intolerance may be already identi-
fied by a suboptimal maternal glucose 
metabolism in early pregnancy.
►	Preventive strategies aiming to improve 
childhood cardiometabolic health may 
be more effective when optimizing ma-
ternal weight status before pregnancy 
than maternal glucose metabolism.
Introduction
Gestational diabetes is associated with increased risks of offspring obesity, type 2 diabetes, 
and metabolic syndrome (1-5). Increasing evidence has suggested that these risks might not 
be confined to women diagnosed with gestational diabetes but that they may already exist 
in offspring exposed to maternal glucose concentrations below diagnostic thresholds (6,7). 
Previous studies have reported associations of maternal glucose concentrations in mid- and 
late pregnancy with offspring cardiometabolic risk factors (6,7). However, as fetal cardio-
vascular and metabolic development already starts in the first trimester, early pregnancy 
may already be a critical period for the adverse influence of a suboptimal maternal glucose 
metabolism on the development of the fetal cardiometabolic system. Increases of maternal 
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glucose and insulin concentrations from early pregnancy onward may 
directly affect placental development and increase nutrient transfer to 
the developing fetus. This may subsequently lead to increased fetal 
growth as well as adaptations in adipogenesis and pancreatic and vas-
cular development. These adaptations may increase the susceptibility to 
cardiometabolic disease in later life (4,8-12). Altered childhood body 
fat development may especially be involved in the associations of ma-
ternal glycemia with offspring cardiometabolic risk factors (9). A few 
studies have shown an association of maternal fasting glucose concen-
trations in pregnancy with increased childhood sum of skinfolds and 
waist circumference (6,7,13). However, it is not clear whether this in-
cludes overall fat or more specifically visceral fat accumulation, which 
is known to be more  strongly related with cardiometabolic disease 
(14,15). We hypothesized that higher maternal early-pregnancy glucose 
concentrations are associated with an unfavorable offspring cardiomet-
abolic risk profile and suboptimal body fat distribution.
Therefore, in a population-based prospective cohort from early preg-
nancy onward among 3,737 mothers and their children, we assessed 
the associations of maternal early-pregnancy glucose and insulin 
concentrations across the full range with cardiometabolic risk factors 
and detailed measurements of general and abdominal fat in child-
hood. We additionally explored whether these associations are inde-
pendent of maternal lifestyle factors and birth, infant, or childhood 
characteristics.
Methods
Study design and participants
This study was embedded in the Generation R Study, a popula-
tion-based prospective cohort study from early pregnancy onward in 
Rotterdam, The Netherlands (16). Approval for the study was obtained 
from the Medical Ethical Committee of Erasmus University Medical 
Center, Rotterdam. Written consent was obtained from the parents of 
all participants. In total, 8,879 pregnant women were enrolled between 
2001 and 2005. Of these, 6,117 mothers had early-pregnancy informa-
tion on glucose and insulin concentrations available and had singleton 
live-born children. Cardiometabolic follow-up measurements at the age 
of 10 years were available for 3,737 of their children (Figure 1). Main 
reasons for missing data were participants lost to follow-up and no con-
sent or failure of venous punctures (16).
Maternal early-pregnancy glucose and insulin 
concentrations
Nonfasting blood samples were collected at enrollment in the study be-
fore 18 weeks of gestation (median: 13.2 weeks; 95% range: 10.5-17.1). 
Glucose concentration (millimoles per liter) is an enzymatic quantity and 
was measured with c702 module on the Cobas 8000 analyzer  (Roche, 
Almere, the Netherlands). Insulin concentration (picomoles per liter) was 
measured with electrochemiluminescence immunoassay on the Cobas 
e411 analyzer (Roche).
Figure 1 Flowchart of the study participants.
n= 6257 
Mothers enrolled during pregnancy with information on early-
pregnancy glucose or insulin levels available 
n= 140
Excluded:  
Twin pregnancies 
n=3737 
Population for analyses: 
Mother-singleton child couples with information available on 
maternal early-pregnancy glucose or insulin levels and childhood 
cardio-metabolic risk factors 
Childhood cardio-metabolic risk factors 
BMI n=3726
Blood pressure n=3603
Cholesterol n=2589
High-density lipoprotein-cholesterol n=2589
Triglycerides n=2584
Glucose n=2589
Insulin n=2583
Childhood general and abdominal fat
Total body fat mass n=3691
Android/gynoid fat mass ratio n=3691
Subcutaneous fat mass n=1923
Visceral fat mass n=1923
n= 6117
Mothers enrolled during pregnancy with information on early-
pregnancy glucose or insulin levels available and singleton live 
births  
n= 3335
Excluded: 
No participation in follow up 
measurements at 10 years 
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Childhood cardiometabolic risk factors and 
general and abdominal fat measurements
At the age of 10 years, we measured height and weight without 
shoes and heavy clothing and calculated BMI (kilograms per meter 
squared). Childhood BMI standard deviation scores (SDS) adjusted 
for sex and age were constructed based on Dutch reference growth 
charts (Growth Analyzer 4.0; Dutch Growth Research Foundation, 
Rotterdam, Netherlands) (17). We defined childhood overweight and 
underweight by categorizing childhood weight status according to the 
International Obesity Task Force cutoffs (18). Overweight and obe-
sity were combined into one category, and children with underweight 
were excluded only in this variable (n = 266). We observed similar 
results when children with underweight were included in the analyses 
(results not shown). Systolic and diastolic blood pressures (millime-
ters of mercury) were measured at the right brachial artery, four times 
with 1-minute intervals, using the validated automatic sphygmanom-
eter Datascope Accutorr Plus (Paramus, New Jersey) (19). Mean 
systolic and diastolic blood pressure values were calculated using 
the last three blood pressure measurements. We obtained nonfasting 
venous blood samples and measured total cholesterol (millimoles 
per liter), high-density lipoprotein  (HDL) cholesterol (millimoles 
per liter), triglycerides (millimoles per liter), glucose (millimoles per 
liter), and insulin (picomoles per liter) concentrations.
We measured total, android, and gynoid body fat mass by dual-en-
ergy x-ray absorptiometry (Lunar  iDXA; GE Healthcare, Madison, 
Wisconsin) and calculated android/gynoid fat mass ratio (20). 
Abdominal subcutaneous and visceral fat measures were obtained 
from magnetic resonance imaging (MRI) scans using a 3.0-T MRI 
(Discovery MR750w; GE Healthcare, Milwaukee, Wisconsin) as 
described previously (16,21). Childhood body fat mass is strongly 
influenced by height of the child (22). To enable assessment of the 
associations of maternal glucose metabolism with childhood adi-
posity measures independent of childhood size, we constructed 
childhood fat mass measures independent of height of the child. 
Using log-log regressions, we estimated the optimal adjustment for 
childhood height needed to construct height-independent fat mass 
measures (details in online  Supporting Information Methods 1) 
(22-24). We calculated total fat mass and subcutaneous fat mass indices 
(total and subcutaneous fat mass/height4) and visceral fat mass index 
(visceral fat mass/height3).
Clustering of cardiometabolic risk factors was defined as having three 
or more of the following components: visceral fat mass index ≥ 75th 
percentile, systolic or diastolic blood pressure ≥ 75th percentile, tri-
glycerides ≥ 75th percentile, or HDL cholesterol ≤ 25th percentile; 
and insulin ≥ 75th percentile (25). Because waist circumference was 
not available, we used visceral fat mass index as a proxy for waist 
circumference.
Covariates
Information on maternal educational level, ethnicity, parity, weight 
just before pregnancy, maximum weight during pregnancy, smoking, 
and total daily energy intake (in kilojoules) during pregnancy was 
obtained through questionnaires (16). Maternal height was measured 
at intake without shoes and BMI was calculated (16). We obtained 
information about diagnosis of gestational diabetes and child’s sex, 
gestational age at birth, and birth weight from medical records (16). 
Preterm birth was defined as a gestational age at birth < 37 weeks. We 
created gestational age- and sex-adjusted SDS of birth weight using 
North-European reference growth charts (26). We defined small for 
gestational age and large for gestational age at birth as the lowest and 
the highest 10 percentiles of gestational-age–adjusted birth weight, 
respectively. We obtained information on breastfeeding in infancy by 
questionnaire (16).
Statistical analysis
First, we performed a nonresponse analysis to compare children 
with and without follow-up measurements at the age of 10 years. 
Second, we assessed the associations of maternal early-pregnancy 
glucose and insulin concentrations across the full range with the risks 
of childhood overweight and clustering of cardiometabolic risk fac-
tors using multiple logistic regression models. Third, we used mul-
tiple linear regression models to assess the associations of maternal 
early-pregnancy glucose and insulin concentrations with childhood 
BMI, blood pressure, lipids, and glucose and insulin concentrations 
across the full range separately and with detailed childhood general 
and abdominal fat measurements. We used three different models for 
the analyses. The first was the basic model, which was adjusted for 
gestational age at enrollment and child’s age and sex at follow-up 
measurements. The second was the confounder model, which was the 
basic model additionally adjusted for confounding covariates and was 
considered as the main model. Based on literature, maternal ethnicity, 
educational level, parity, smoking, and daily total caloric intake were 
considered as potential confounders. Only maternal ethnicity and ed-
ucational level were selected in the model based on their association 
with exposures and outcomes and change in effect estimates of > 10% 
in our study sample. The third model was the maternal BMI model, 
which was the confounder model additionally adjusted for maternal 
prepregnancy BMI. Because previous studies have suggested that 
associations between gestational diabetes and childhood BMI are 
largely explained by maternal prepregnancy BMI, we constructed 
this  separate maternal prepregnancy BMI model (12). Correlation 
coefficients for correlation between maternal glucose and insulin 
concentrations and prepregnancy BMI were 0.16 and 0.20 for ma-
ternal glucose and insulin concentrations, respectively. For associa-
tions that persisted after adjustment for maternal prepregnancy BMI, 
we further explored whether these associations were mediated by 
gestational weight gain, birth weight, infant breastfeeding, or child-
hood BMI by adding these variables separately to the maternal BMI 
model. We tested for interactions of maternal glucose and insulin 
with maternal BMI, maternal ethnicity, and child’s sex, but none was 
significant and no further stratified analyses were performed (27-29). 
We performed the following sensitivity analyses: (1) we excluded 
women with a diagnosis of gestational diabetes (n = 34) because we 
were interested in the associations of maternal glucose and insulin 
concentrations within a nondiabetic population; (2) we repeated the 
analyses excluding children born preterm, small for gestational age 
at birth, or large for gestational age at birth to explore whether these 
adverse birth outcomes explained potential associations.
Not normally distributed exposure and outcome measures were log 
transformed. To enable comparison of effect estimates, we con-
structed SDS of exposures and outcomes. To reduce selection bias 
because of missing data, multiple imputations of covariates (pooled 
results of five imputed data sets) were performed (30). We applied 
Bonferroni correction to take multiple testing into account. As out-
comes were strongly correlated, we divided the α of 0.05 by four 
categories (fat measures, blood pressure, lipid concentrations, and 
glucose/insulin concentrations), resulting in P < 0.013. All analyses 
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were performed using SPSS Statistics version 24.0 for Windows 
(IBM Corp., Armonk, New York).
Results
Characteristics of study participants
Table 1 shows the population characteristics. In early pregnancy, the 
mean maternal glucose concentration was 4.4 mmol/L (SD 0.9) and 
the median insulin concentration was 114.0 pmol/L (95% range: 
24.1-491.8). Nonresponse analyses showed that mothers of children 
included in the analyses compared with mothers lost to follow-up were, 
on average, older, more frequently European, and more highly educated 
and that they had a higher prepregnancy weight and had children with 
a higher birth weight. No differences in early-pregnancy glucose and 
insulin concentrations were present (Supporting Information Table S1).
Childhood cardiometabolic risk factors
Figure 2 shows that, in the confounder model, 1-SDS higher mater-
nal early-pregnancy glucose and insulin concentrations were asso-
ciated with an increased risk of childhood overweight (odds ratio 
[OR] 1.14, 95% CI: 1.04-1.24 and OR 1.20, 95% CI: 1.10-1.32 per 
SDS increase in maternal glucose and insulin concentrations, respec-
tively). A 1-SDS higher maternal early-pregnancy insulin concentra-
tion, but not glucose concentration, was associated with clustering 
of cardiometabolic risk factors in childhood (OR 1.20, 95% CI: 
1.04-1.38 per SDS increase in maternal insulin concentration). All of 
these associations attenuated to nonsignificance after adjustment for 
maternal prepregnancy BMI.
Table 2 shows the associations of maternal glucose and insulin con-
centrations with each of the childhood cardiometabolic risk factors 
separately. In the confounder model, a 1-SDS higher maternal glucose 
concentration was associated with lower HDL cholesterol (−0.04 SDS, 
95% CI: −0.08 to −0.01 per SDS increase in glucose concentration). 
A 1-SDS higher maternal insulin concentration was associated with 
higher childhood BMI (0.05 SDS, 95% CI: 0.02 to 0.08 per SDS 
increase in insulin concentration) and systolic blood pressure (0.04 
SDS, 95% CI: 0.01 to 0.07 per SDS increase in insulin concentration). 
These associations attenuated to nonsignificance after adjustment for 
maternal prepregnancy BMI. A 1-SDS higher maternal early-pregnancy 
glucose concentration was associated with higher glucose concentra-
tion in childhood (0.08 SDS, 95% CI: 0.04-0.11 per SDS increase in 
maternal glucose concentration), whereas a  1-SDS higher maternal 
early-pregnancy insulin concentration was  associated with higher 
childhood insulin concentration (0.07 SDS, 95% CI: 0.03-0.10 per SDS 
increase in maternal insulin concentration). The association of mater-
nal glucose concentration with childhood glucose concentration was 
not affected by additional adjustment for maternal prepregnancy BMI, 
whereas the association of maternal early-pregnancy insulin concen-
tration with childhood insulin concentration only slightly attenuated 
after adjustment for maternal prepregnancy BMI. Further adjustment 
for gestational weight gain, birth weight, infant breastfeeding, and 
childhood BMI did not materially affect the associations (Supporting 
Information Table S2).
Childhood general and abdominal fat
Table 3 shows that in the confounder model, a 1-SDS higher maternal 
early-pregnancy insulin concentration, but not glucose concentration, 
TABLE 1 Characteristics of study population
 
Total group 
(n = 3,737)
Maternal characteristics  
Age at enrollment, mean (SD), y 30.7 (4.7)
Height, mean (SD), cm 168.2 (7.4)
Prepregnancy weight, median (95% range), kg 65.0 (50.3-90.0)
Prepregnancy BMI, median (95% range), kg/m2 22.6 (18.8-31.9)
Ethnicity, n (%)  
Dutch 2,193 (58.7)
European 299 (8.0)
Cape Verdean 153 (4.1)
Dutch Antillean 66 (1.8)
Moroccan 169 (4.5)
Surinamese 272 (7.3)
Turkish 218 (5.8)
Education, n high (%) 1,855 (49.6)
Parity, n nulliparous (%) 2,230 (59.7)
Smoking during pregnancy, n yes (%) 853 (22.8)
Gestational weight gain, mean (SD), kg 15.1 (5.7)
Daily energy intake, mean (SD), kJ 8,581 (2,294)
Gestational age at intake, median (95% range), wk 13.2 (10.5-17.1)
Glucose concentration, mean (SD), mmol/L 4.4 (0.9)
Insulin concentration, median (95% range), pmol/L 114.0 
(24.1-491.8)
Gestational diabetes, n (%) 34 (0.9)
Infant characteristics  
Sex, n female (%) 1,894 (50.7)
Gestational age at birth, median (95% range), wk 40.3  
(37.1-42.1)
Birth weight, mean (SD), g 3,437 (550)
Small for gestational age, n (%) 373 (10.0)
Large for gestational age, n (%) 373 (10.0)
Preterm birth, n (%) 155 (4.1)
Ever breastfed, n yes (%) 2,878 (77.0)
Childhood characteristics  
Age, mean (SD), y 9.8 (0.4)
Height, mean (SD), cm 141.6 (6.7)
Weight, median (95% range), kg 33.8 (26.4-49.7)
BMI, median (95% range), kg/m2 16.9 (14.4-23.3)
Fat  
Total fat mass, median (95% range) 8,417 
(4,905-19,116)
Android/gynoid fat mass ratio, median (95% range) 0.24 (0.16-0.44)
Subcutaneous fat mass, median (95% range), g 1,294 
(642-4,271)
Visceral fat mass, median (95% range), g 369 (187-853)
Blood pressure  
Systolic, mean (SD), mmHg 103.1 (7.9)
Diastolic, mean (SD), mmHg 58.5 (6.4)
Lipid concentrations  
Total cholesterol, mean (SD), mmol/L 4.31 (0.66)
High-density lipoprotein cholesterol, mean (SD), 
mmol/L
1.48 (0.34)
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was associated with higher childhood total fat mass index (0.06 SDS, 
95% CI: 0.03-0.09 per SDS increase in insulin concentration), android/
gynoid fat mass ratio (0.05 SDS, 95% CI: 0.02-0.08 per SDS increase 
in insulin concentration), and subcutaneous fat mass index (0.07 SDS, 
95% CI: 0.03-0.11 per SDS increase in insulin concentration). All of 
these associations of maternal insulin concentration with childhood 
total fat mass index, android/gynoid fat mass ratio, and abdominal sub-
cutaneous fat mass index attenuated to nonsignificance after adjustment 
for maternal prepregnancy BMI. No associations of maternal glucose 
or insulin concentrations with childhood visceral fat mass index were 
present.
Sensitivity analyses
No differences in findings were present when mothers with gesta-
tional diabetes were excluded from the analyses (data not shown). 
We observed largely similar results when children with adverse birth 
outcomes were excluded from the analyses (Supporting Information 
Tables S3-S6).
Discussion
In this prospective cohort study, we observed that higher maternal ear-
ly-pregnancy glucose and insulin concentrations were associated with 
higher childhood glucose and insulin concentrations at the age of 10 
years. The associations of maternal early-pregnancy glucose and insulin 
concentrations with other childhood cardiometabolic risk factors and 
detailed measurements of general and abdominal fat were explained by 
maternal prepregnancy BMI.
Interpretation of main findings
A high number of pregnancies are complicated by gestational di-
abetes. Next to an increased risk of maternal complications, intra-
uterine exposure to gestational diabetes is associated with adverse 
cardiometabolic outcomes in the offspring (4). Previous studies have 
already reported associations between higher late-pregnancy  ma-
ternal glucose concentrations already  below the clinical threshold 
of gestational diabetes with offspring cardiometabolic risk factors 
(6,31,32). A study among 970 Chinese mother-child pairs reported 
that third-trimester maternal fasting glucose concentrations were as-
sociated with a higher risk for obesity, higher systolic blood pressure, 
and abnormal glucose tolerance at the age of 7 years, independent 
of maternal prepregnancy BMI (6). A cohort study in the United 
Kingdom including 2,563 women and their offspring showed that, 
independent of maternal prepregnancy BMI, glycosuria in midpreg-
nancy was associated with higher offspring BMI and fasting insulin 
concentrations but not with blood pressure and lipid concentrations 
(31). It is likely that women who develop gestational diabetes or hy-
perglycemia later in pregnancy already have a suboptimal glucose 
metabolism in early pregnancy, a critical period for placental and 
fetal cardiometabolic development (9,33). Suboptimal maternal glu-
cose and insulin concentrations in early pregnancy may adversely 
affect placental development, predisposing to alterations in fetal nu-
trient supply, growth, and development (34). In addition, suboptimal 
maternal early-pregnancy glucose concentrations may have direct 
adverse influences on fetal cardiometabolic development (9).
In the current study, we observed that higher maternal glucose and 
insulin concentrations in early pregnancy were associated with higher 
childhood risks of overweight and clustering of cardiometabolic risk 
factors. However, these associations attenuated after adjustment for 
maternal prepregnancy BMI. These findings suggest that maternal pre-
pregnancy BMI, a known risk factor for insulin resistance in pregnancy 
and cardiometabolic risk factors in childhood, explains the associations 
of maternal early-pregnancy glucose and insulin concentrations with 
childhood overweight and cardiometabolic risk factors (9). When we 
further explored the associations of maternal early-pregnancy glucose 
and insulin concentrations with individual cardiometabolic risk factors, 
we observed that higher maternal glucose and insulin concentrations 
were associated with higher offspring glucose and insulin concentra-
tions, respectively. These associations were independent of mater-
nal prepregnancy BMI, gestational weight gain, birth weight, infant 
breastfeeding, and childhood BMI. Findings were also similar when 
we excluded children with adverse birth outcomes from the analyses. 
Thus, these factors do not seem to explain the associations of maternal 
 
Total group 
(n = 3,737)
Triglycerides, median (95% range), mmol/L 0.98 (0.47-2.28)
Glucose, mean (SD), mmol/L 5.20 (0.94)
Insulin, median (95% range), pmol/L 174.60 
(45.87-512.40)
Overweight/obesity, n (%) 643 (17.2)
Clustering of cardiometabolic risk factors, n (%) 261 (7.1)
TABLE 1 (continued).
Figure 2 Associations of maternal early-pregnancy glucose and insulin concentrations 
and childhood risks of overweight and clustering of cardiometabolic risk factors. 
Values represent odds ratios (95% CI) from logistic regression models that reflect 
the risks of childhood overweight for SDS change in maternal glucose and insulin 
concentrations. aBasic model includes gestational age at enrollment and child’s age 
and sex at follow-up measurements. bConfounder model includes the basic model 
additionally adjusted for ethnicity and maternal educational level. cMaternal BMI model 
includes the confounder model additionally adjusted for maternal prepregnancy BMI.
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glucose and insulin concentrations with childhood glucose metabo-
lism. This suggests that at least part of the association may be due to 
an intrauterine effect of maternal glucose and insulin concentrations on 
offspring glucose metabolism. Similar to previous studies performed 
later in pregnancy using fasting glucose samples, we did not find an 
association of maternal early-pregnancy glucose and insulin concen-
trations with childhood BMI, blood pressure, and lipid concentrations, 
independent of maternal prepregnancy BMI (31). Thus, our results sug-
gest that maternal glucose and insulin concentrations, as soon as early 
pregnancy, are related to higher childhood glucose and insulin concen-
trations, irrespective of maternal, birth, and childhood characteristics, 
but not to other cardiometabolic outcomes. Whether maternal factors 
other than impaired glucose metabolism as a consequence of higher 
maternal BMI, such as altered maternal hormone status, play a role in 
the association of maternal prepregnancy BMI with childhood BMI, 
blood pressure, and lipids should be further studied.
Animal and mechanistic studies proposed that offspring fat accumu-
lation and adverse fat distribution might be involved in the associa-
tions of maternal hyperglycemia with offspring cardiometabolic risk 
factors. Observational studies have  confirmed this hypothesis and 
reported associations of maternal fasting glucose concentrations in 
pregnancy with adverse offspring body fat composition, measured by 
sum of skinfolds and waist circumference (6,7,31,35,36). However, 
these measures are suboptimal, as waist circumference does not dis-
tinguish subcutaneous from visceral fat, whereas visceral abdominal 
fat is much more closely related to risk of cardiometabolic disease in 
later life (14). In the present study, we observed that higher maternal 
early-pregnancy insulin concentrations but not glucose concentrations 
were associated with childhood total body fat mass, android/gynoid fat 
mass ratio, and subcutaneous abdominal fat mass. In line with the asso-
ciations of maternal glucose and insulin concentrations with childhood 
BMI, blood pressure, and lipids, all associations of maternal glucose 
and insulin concentrations with detailed measurements of childhood 
general and abdominal fat in the present study were fully explained by 
maternal prepregnancy BMI. Contrary to our hypothesis, no specific 
associations with childhood visceral fat mass were present. It might be 
that associations with childhood visceral fat are more apparent among 
higher risk populations or at older ages. Further studies are needed to 
explore the detailed role of a suboptimal offspring body fat distribution 
in response to impaired maternal glucose metabolism during pregnancy 
within different populations and using advanced imaging techniques. 
Based on our results, it seems that maternal early-pregnancy glucose 
and insulin concentrations are associated with childhood subcutaneous 
fat accumulation, but these associations are explained by maternal pre-
pregnancy BMI.
Within this study, we only observed independent associations of 
maternal early-pregnancy glucose and insulin concentrations with 
childhood glucose and insulin concentrations. These associations 
provide insight into potential underlying mechanisms, and they may 
be explained through several pathways. First, shared genetic fac-
tors are expected to have a contribution in the association between 
maternal glucose and insulin concentrations with offspring glucose 
and insulin concentrations (37). Second, higher maternal early- 
pregnancy glucose concentrations lead to fetal hyperinsulinemia, 
whereas higher maternal early-pregnancy insulin concentrations 
are involved in protein, lipolysis, and early placental development. 
Together, this could cause alternations in fetal nutrient supply, affect-
ing fetal pancreatic beta-cell development and increasing fetal insu-
lin secretion. These irreversible alterations may subsequently lead to TA
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increased glucose and insulin concentrations in childhood (9,38,39). 
Furthermore, higher maternal glucose concentrations may also be 
involved in gene expression through DNA methylation, leading to 
altered insulin secretion in the offspring (40). Further studies are 
needed to disentangle the complex mechanisms underlying the asso-
ciation of maternal glucose and insulin concentrations with child-
hood glucose metabolism.
The observed effect estimates for the associations of maternal ear-
ly-pregnancy glucose and insulin concentrations with childhood glu-
cose and insulin concentrations were relatively small but they may 
be important on a population level. Previous studies have shown that 
childhood glucose and insulin concentrations tend to track into adult-
hood. A study among 1,766 children showed that children with higher 
fasting glucose concentrations at the age of 10 years had a higher risk 
of developing type 2 diabetes in adolescence (6). Similarly, a study 
among 1,723 children reported that children with higher fasting glu-
cose concentrations within the normal range had a higher risk of pre-
diabetes and type 2 diabetes in adulthood (7). A study among 4,857 
American Indian children without diabetes showed that children with 
higher glucose concentrations after a glucose tolerance test had a 
higher risk of premature death, but this effect was not independent 
of concurrent childhood BMI (41). Together, these findings suggest 
that even subclinical differences in childhood glucose and insulin 
concentrations may be related to the development of type 2 diabe-
tes in later life (42). Maternal prepregnancy BMI seems to explain 
the associations of maternal glucose and insulin concentrations with 
other childhood cardiometabolic risk factors and childhood body 
fat development. This suggests that preventive strategies, aimed at 
improving offspring cardiometabolic health, might be more effective 
when focusing on optimizing maternal prepregnancy BMI than on 
optimizing maternal glucose concentrations from early  pregnancy 
onward.
Methodological considerations
Strengths of this study are the prospective design, large sample size, 
and the use of detailed fat measures obtained through MRI. Although 
only 61% of children from mothers with information on glucose and 
insulin concentrations in pregnancy participated in follow-up mea-
surements, we do not expect that nonresponse affected our effect 
estimates, as maternal insulin and glucose concentrations did not 
differ between these groups. The generalizability of our results may 
be affected by a selection toward a relatively healthy, high-educated 
study population. We obtained nonfasting glucose and insulin con-
centrations, sampled on nonfixed times throughout the day. This may 
have led to nondifferential misclassification, causing an underesti-
mation of our associations. Although we simultaneously measured 
insulin concentrations to substantiate our findings, random glucose 
concentrations cannot directly assess insulin resistance. However, 
random glucose concentrations are useful for identifying women at 
risk for gestational diabetes and they  are used in clinical practice 
as a screening method in early pregnancy (43,44). In addition, we 
measured maternal glucose and insulin concentrations once during 
early pregnancy. Impaired glucose tolerance in early pregnancy has 
been suggested to persist throughout pregnancy (33). Further studies 
are needed with multiple, more detailed maternal glucose measure-
ments, including fasting glucose concentrations and detailed post-
prandial glucose measurements throughout pregnancy. These studies 
also need to use more advanced statistical methods to provide further 
insight into critical periods for potential adverse effects of impaired 
maternal glucose metabolism on offspring glucose metabolism. We 
did not have information available on clinical diagnosis of type 
2 diabetes in the offspring. However, we expect the percentage of 
childhood type 2 diabetes according to clinical diagnosis within our 
cohort to be low, as the average age of the children in our cohort is 
9.8 years, whereas the onset of type 2 diabetes mostly occurs at later 
childhood ages (45). Further studies are needed to assess whether 
maternal early-pregnancy glucose and insulin concentrations are also 
associated with the risk of type 2 diabetes in the offspring during ad-
olescence. Finally, although we had detailed information on maternal 
and childhood sociodemographic and lifestyle factors available, be-
cause of the observational study design, residual confounding by, for 
example, childhood dietary factors and physical activity may have 
influenced our results.
Conclusion
Maternal early-pregnancy random glucose and insulin concentra-
tions were associated with higher childhood glucose and insulin con-
centrations, independent of maternal and childhood characteristics. 
When taking maternal prepregnancy BMI into account, no associations 
of maternal glucose and insulin concentrations with other childhood 
cardiometabolic risk factors were present.O
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